Your Health Questions Have Genetic Answers. Here's What Your Genes Say.

MTHFR is an enzyme responsible for a fundamental metabolic process called methylation. This process is happening in your cells right now, millions of times per second. It’s how your body converts dietary B vitamins into their active forms, how it produces energy at the mitochondrial level, and how it manufactures neurotransmitters like serotonin and dopamine. Without a properly functioning MTHFR enzyme, all of this slows down.

The C677T variant, carried by roughly 40% of people with European ancestry, reduces MTHFR enzyme efficiency by 40 to 70 percent. That means even if you’re eating plenty of leafy greens and taking B vitamins, your cells can only convert a fraction of them into usable energy and neurotransmitter precursors. The second variant, A1298C, has a similar but slightly less pronounced effect. Many people carry both.

The result feels like running on half power. You might experience chronic tiredness that doesn’t improve with rest, brain fog even after sleeping well, difficulty bouncing back from stress, or a persistently low mood that doesn’t respond to standard antidepressants. Your energy production is literally hobbled at the cellular level.

Vitamin D isn’t just a vitamin. It’s a hormone that acts on almost every cell in your body, including the mitochondria that produce your energy. But vitamin D only works if your cells can actually take it up, and that uptake happens through a receptor called VDR. If your VDR variant reduces its sensitivity, your cells are essentially deaf to the vitamin D circulating in your bloodstream, even if your serum D levels look fine.

The VDR BsmI, FokI, and TaqI variants are extremely common, affecting 30 to 50 percent of the population depending on ancestry. Carriers of certain VDR variants have reduced cellular uptake of vitamin D, which impairs the activation of genes involved in mitochondrial biogenesis. That means your cells struggle to build new functional mitochondria, and the ones you have are less efficient at producing ATP (cellular energy).

You might notice this as persistent fatigue, weak muscles that recover slowly from exercise, a propensity to get sick frequently (vitamin D drives immune function), or depression that doesn’t fully resolve even when your serum vitamin D level is technically adequate. Your bones might feel fragile despite eating enough calcium. Essentially, your cells aren’t getting the vitamin D signal even though you’re supplementing.

COMT is an enzyme that clears dopamine, norepinephrine, and epinephrine from your synapses. These are your nervous system’s activation chemicals. They need to be produced when you face a stressor or need to focus, and then cleared quickly once the stressor passes. If clearance is slow, these chemicals linger, keeping your nervous system in a state of activation long after the threat is gone.

The Val158Met variant creates a functional difference: some people are “fast metabolizers” and some are “slow metabolizers.” Roughly 25 percent of people are homozygous slow metabolizers, meaning they clear these chemicals very slowly. Even a mild stressor or a normal day’s stimulation keeps their nervous system activated into the evening and night. Sleep becomes light and fragmented because their brain is literally too aroused to reach deep sleep.

If you’re a slow COMT metabolizer, you might feel wired at bedtime despite being exhausted, wake up at 3 AM and be unable to fall back asleep, experience anxiety that feels disproportionate to the actual stressor, or feel foggy and scattered from chronic nervous system activation. You might be sensitive to caffeine, stimulant medications, or even the adrenaline of a slightly stressful meeting. Your nervous system is biologically more reactive.

TCF7L2 is one of the strongest genetic predictors of type 2 diabetes risk. The gene regulates how your pancreas responds to blood sugar, how your cells take up glucose, and how efficiently your metabolism partitions energy. A variant in this gene shifts the balance, making blood sugar control harder and insulin resistance more likely, even in young, active people.

The TCF7L2 rs7903146 variant is extremely common. Roughly 30 to 40 percent of the general population carries at least one copy of the risk allele, and risk increases with each copy. The effect isn’t immediate diabetes; rather, it’s a biological propensity toward insulin resistance and metabolic dysfunction that compounds over years if diet and lifestyle don’t account for it.

You might notice this as an unexplained tendency to gain weight easily, especially around the midsection; fatigue after eating carbohydrates, especially refined ones; difficulty losing weight despite a reasonable diet; or a persistent craving for sweets and carbs. Your fasting glucose might be technically normal but creeping upward year after year. You might have been told you’re at risk for prediabetes even though you’re not overweight. Your metabolism simply works differently.

Serotonin is synthesized in the afternoon and evening, when it sets the stage for melatonin production. The SLC6A4 gene codes for the serotonin transporter, which recycles serotonin from the synapse back into the neuron after it’s been used. This recycling is the first step in the serotonin-to-melatonin conversion, which signals your body to sleep.

The 5-HTTLPR short allele variant, carried by roughly 40 percent of people in at least one copy, impairs serotonin reuptake efficiency. Serotonin accumulates and then drops unpredictably, creating an inconsistent serotonin signal that makes melatonin production unreliable. Night after night, your sleep latency (time to fall asleep) is unpredictable, your sleep architecture is fragmented, and you wake feeling unrefreshed despite logging seven or eight hours.

You might experience a specific pattern: you fall asleep okay but wake frequently, or you sleep a full night but feel like you didn’t sleep at all because deep, restorative sleep was never reached. Mood might be inconsistent, with good days and unexpectedly low days. You might have tried SSRIs (which work by blocking serotonin reuptake, which should theoretically help) but found they either didn’t work or had odd side effects because your biology already has unusual serotonin recycling.

APOE is the cholesterol transport and brain health gene. It determines how your body packages cholesterol, how efficiently your brain is repaired and maintained, and your risk for age-related cognitive decline and Alzheimer’s disease. Three common variants exist: APOE2, APOE3, and APOE4. APOE3 is neutral. APOE2 is protective. APOE4 is a risk factor, and the more copies you carry, the higher the risk.

Roughly 25 to 30 percent of the population carries at least one APOE4 allele. This variant doesn’t guarantee you’ll develop Alzheimer’s, but it reduces the margin for error. Your brain is less efficient at clearing amyloid-beta plaques that accumulate with age. Your cholesterol metabolism favors LDL over HDL. Your cognitive reserve is lower, meaning the same amount of brain aging shows up as cognitive decline sooner.

You might notice this as minor cognitive slips earlier than you’d expect for your age, brain fog that’s harder to shake, difficulty learning new information as quickly, or a family history of Alzheimer’s that makes you worried about your own future. Your cholesterol might be harder to manage with diet alone. You might feel like your brain needs more sleep to recover than it used to.